86
60
Growth Score
-4 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
297658
Vixen Bio is a biotechnology company that provides bioanalytical services for the pharmaceutical and clinical development sectors.
- Filip Delport: Co-Founder, Managing Director, and CEO
- Jeroen Lammertyn: Co-Founder
About the Company
Vixen Bio is a biotechnology company that provides bioanalytical services for the pharmaceutical and clinical development sectors. The company focuses on supporting the development of antibody-based therapeutics and diagnostics through immunology-driven analysis and advanced assay technologies.
Its services include assay development, sample
analysis, and biomarker characterization, with the aim of generating data that can inform drug design, clinical trial strategies, and treatment optimization. Vixen Bio works with contract research organizations (CROs), pharmaceutical companies, and biotechnology firms to provide insights across different stages of the development process, from early research through clinical trials.
